In simple terms, Medicenna Therapeutics Corp. has 67.316 M shares that people are buying and selling right now.
Return on Investments
The company's asset efficiency, represented by a robust -0.417% return, is a testament to Medicenna Therapeutics Corp.'s adeptness in optimizing resource deployment. Medicenna Therapeutics Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.410%. Furthermore, the proficiency of Medicenna Therapeutics Corp. in capital utilization is underscored by a remarkable -0.702% return on capital employed.
Stock Prices
Medicenna Therapeutics Corp.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.48, while its low point bottomed out at $0.45. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Medicenna Therapeutics Corp.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
